MediCrops Holding AG focuses on the marketing of medicinal cannabis preparations containing tetrahydrocannabinol (‘THC’).
During the 2021 financial year, MediCrops founded a Swiss subsidiary that will specialise in the production and processing of medicinal cannabis preparations.
The corporate management team at MediCrops Holding AG aims to ensure that transparency and sustainable value are created for all stakeholders.
The focus of the Board of Directors is on the Corporate Governance Framework to ensure a consistent implementation of the best practice standards in accordance with the ‘Swiss Code of Best Practice for Corporate Governance’
Cannabis is cultivated and exported worldwide. In Europe, cannabis is mainly cultivated in Germany, the Netherlands and Italy, and cultivation often takes place in so-called indoor facilities. Due to special cultivation conditions, higher crop yields are achieved than in open field cultivation.
The use of cannabis for medicinal purposes dates back a long way, especially in India and Middle Eastern countries.